Effect of Rab23 on the proliferation and apoptosis in breast cancer

Liu,Yali; Zeng,Chao; Bao,Nandi; Zhao,Jie; Hu,Yuzhen; Li,Chengxin; Chi,Sumin

doi:10.3892/or.2015.4152

Effect of Rab23 on the proliferation and apoptosis in breast cancer

Authors:
- Yali Liu
- Chao Zeng
- Nandi Bao
- Jie Zhao
- Yuzhen Hu
- Chengxin Li
- Sumin Chi
View Affiliations

Affiliations: Department of Physiology, State Key Discipline of Cell Biology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Team 2, Cadet Brigade, School of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China, Department of Dermatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China
Published online on: July 24, 2015 https://doi.org/10.3892/or.2015.4152
Pages: 1835-1844

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rab23, as a negative regulatory molecule of the Hedgehog (Hh) signaling pathway, may be a new target for treating carcinoma. In the present study, we aimed to determine whether Rab23 is expressed in breast cancer cells and whether Rab23 affects the viability and proliferation of breast cancer cells. We evaluated Rab23 expression in several breast cancer cell lines including MDA-MB-231, Bcap37 and MCF-7 by reverse transcription-PCR (RT-PCR), western blotting and immunofluorescence in vitro. We assessed cell growth and proliferation by 3-(4,5-dimethylthiazol‑2-y1)‑3,5-diphenyltetrazolium bromide (MTT), colony formation and bromodeoxyuridine (BrdU) incorporation assays. The distribution of the cell cycle and the rate of apoptosis were assessed using flow cytometry (FCM). In addition, we determined the mechanisms by which Rab23 regulates the Hh pathway by detecting the level of Gli molecules by RT-PCR. We found that Rab23 mRNA and protein levels were expressed in breast cancer cells, and the expression of Rab23 in MDA-MB-231 cells was higher than that in the MCF-7 cells. Rab23 protein was primarily expressed and localized in the cytoplasm surrounding the nucleus. The MTT assay showed that the absorbance value at A490 nm of the Rab23‑transfected group was reduced in comparison with the control group. The number of colonies formed in the breast cancer cells was significantly reduced and BrdU labeling was weakened in the group transfected with Rab23. The results of FCM showed that overexpression of Rab23 protein caused cell cycle arrest in the G1 phase and a decrease in the S phase population as well as induction of apoptosis. Furthermore, Rab23 decreased Gli1 and Gli2 mRNA levels when compared with the control group. Our results indicate that Rab23 is expressed in breast cancer cells, and ectopic expression of Rab23 inhibits the growth and proliferation as well as induces cell apoptosis in breast cancer cells. These effects may be due to the inhibition by Rab23 of Gli1 and Gli2 mRNA expression. These results suggest that Rab23 is a potential target for the treatment of breast cancer.

View Figures

View References

1	Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A and Jordan VC: Early breast cancer. Lancet. 373:1463–1479. 2009. View Article : Google Scholar : PubMed/NCBI
2	Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
3	McMahon AP, Ingham PW and Tabin CJ: Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol. 53:1–114. 2003. View Article : Google Scholar : PubMed/NCBI
4	Saldanha G: The Hedgehog signalling pathway and cancer. J Pathol. 193:427–432. 2001. View Article : Google Scholar : PubMed/NCBI
5	Kasper M, Jaks V, Fiaschi M and Toftgård R: Hedgehog signalling in breast cancer. Carcinogenesis. 30:903–911. 2009. View Article : Google Scholar : PubMed/NCBI
6	Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ and Weber BL: High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 7:R1186–R1198. 2005. View Article : Google Scholar
7	Nessling M, Richter K, Schwaenen C, Roerig P, Wrobel G, Wessendorf S, Fritz B, Bentz M, Sinn HP, Radlwimmer B, et al: Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res. 65:439–447. 2005.PubMed/NCBI
8	Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY and Koeffler HP: Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat. 105:139–155. 2007. View Article : Google Scholar : PubMed/NCBI
9	Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, et al: Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther. 5:674–683. 2006. View Article : Google Scholar : PubMed/NCBI
10	Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC and Lewis MT: Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development. 134:1231–1242. 2007. View Article : Google Scholar : PubMed/NCBI
11	Iorns E, Turner NC, Elliott R, Syed N, Garrone O, Gasco M, Tutt AN, Crook T, Lord CJ and Ashworth A: Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell. 13:91–104. 2008. View Article : Google Scholar : PubMed/NCBI
12	Liu YJ, Wang Q, Li W, Huang XH, Zhen MC, Huang SH, Chen LZ, Xue L and Zhang HW: Rab23 is a potential biological target for treating hepatocellular carcinoma. World J Gastroenterol. 13:1010–1017. 2007. View Article : Google Scholar : PubMed/NCBI
13	Kim KR, Oh SY, Park UC, Wang JH, Lee JD, Kweon HJ, Kim SY, Park SH, Choi DK, Kim CG, et al: Gene expression profiling using oligonucleotide microarray in atrophic gastritis and intestinal metaplasia. Korean J Gastroenterol. 49:209–224. 2007.In Korean. PubMed/NCBI
14	Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 272:1668–1671. 1996. View Article : Google Scholar : PubMed/NCBI
15	Wicking C, Smyth I and Bale A: The hedgehog signalling pathway in tumorigenesis and development. Oncogene. 18:7844–7851. 1999. View Article : Google Scholar
16	Ruiz i Altaba A, Mas C and Stecca B: The Gli code: An information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17:438–447. 2007. View Article : Google Scholar : PubMed/NCBI
17	Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP and Beachy PA: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclo-pamine. Nature. 406:1005–1009. 2000. View Article : Google Scholar : PubMed/NCBI
18	Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, et al: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 297:1559–1561. 2002. View Article : Google Scholar : PubMed/NCBI
19	Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res. 64:6071–6074. 2004. View Article : Google Scholar : PubMed/NCBI
20	Zhang X, Harrington N, Moraes RC, Wu MF, Hilsenbeck SG and Lewis MT: Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo). Breast Cancer Res Treat. 115:505–521. 2009. View Article : Google Scholar
21	Wang HB, Liu YL, Hu YZ and Chi SM: Effect of cyclopamine on growth and proliferation of human mammary carcinoma cell Bcap-37. J Med Postgraduates. 20:567–571. 2007.In Chinese.
22	Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, et al: Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res. 68:4623–4630. 2008. View Article : Google Scholar : PubMed/NCBI
23	Evans TM, Simpson F, Parton RG and Wicking C: Characterization of Rab23, a negative regulator of sonic hedgehog signaling. Methods Enzymol. 403:759–777. 2005. View Article : Google Scholar
24	Eggenschwiler JT, Bulgakov OV, Qin J, Li T and Anderson KV: Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins. Dev Biol. 290:1–12. 2006. View Article : Google Scholar
25	Chi S, Xie G, Liu H, Chen K, Zhang X, Li C and Xie J: Rab23 negatively regulates Gli1 transcriptional factor in a Su(Fu)-dependent manner. Cell Signal. 24:1222–1228. 2012. View Article : Google Scholar : PubMed/NCBI